List of insiders holdings for ChemoCentryx Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Vifor (International) Ltd Vifor Pharma Ltd. Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner |
2021-10-13 19:05:19 | 0 5,194,085 |
5,194,085 | Form 4 |
| 2 | TECHNE CORP 10% Owner |
2019-04-15 17:00:29 | 3,987,654 0 |
3,987,654 | Form 13G |
| 3 | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP I LLC ISALY SAMUEL D 10% Owner |
2012-02-15 19:31:22 | 0 908,509 |
908,509 | Form 4 |
| 4 | Bekker Petrus Chief Medical Officer |
2017-07-13 19:46:45 | 721,519 0 |
721,519 | Form 4 |
| 5 | Fairey William Chief Operating Officer |
2018-01-05 19:45:16 | 575,000 0 |
575,000 | Form 4 |
| 6 | Charo Israel SVP, Research |
2014-09-22 16:44:49 | 175,000 0 |
175,000 | Form 4 |
| 7 | SINGH RAJINDER SVP, Research |
2019-04-17 18:46:12 | 157,614 0 |
157,614 | Form 4 |
| 8 | LUCAS ROGER C Director |
2019-03-08 19:20:43 | 102,267 0 |
102,267 | Form 4 |
| 9 | Kwan Pui San Principal Acctg Officer |
2021-03-01 20:54:05 | 84,353 0 |
84,353 | Form 4 |
| 10 | MCKINNELL HENRY A Director |
2022-05-24 19:34:12 | 72,749 0 |
72,749 | Form 4 |
| 11 | Jaen Juan C. SVP, Drug Discovery & CSO |
2013-07-26 13:48:45 | 70,000 0 |
70,000 | Form 4 |
| 12 | YAU YI CHING SVP, Finance & Acctg Officer |
2022-06-08 18:33:46 | 65,000 0 |
65,000 | Form 4 |
| 13 | KLEIN IRA Director |
2015-05-26 17:41:02 | 28,011 0 |
28,011 | Form 4 |
| 14 | PENHOET EDWARD Director |
2013-05-24 20:04:33 | 12,500 0 |
12,500 | Form 4 |
| 15 | Gupta Rishi Director |
2012-06-26 13:03:53 | 12,500 0 |
12,500 | Form 4 |
| 16 | Jain Rita EVP, Chief Medical Officer |
2022-10-24 19:13:58 | 0 0 |
0 | Form 4 |
| 17 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INC LAMPERT MARK N BVF INVESTMENTS LLC See Explanation of Responses |
2020-02-14 15:09:41 | 0 0 |
0 | Form 13G |
| 18 | Herron Jennifer Lyn Director |
2022-10-24 19:10:07 | 0 0 |
0 | Form 4 |
| 19 | Edwards Thomas A. Director |
2022-10-24 19:10:02 | 0 0 |
0 | Form 4 |
| 20 | Parker Geoffrey M. Director |
2022-10-24 19:08:17 | 0 0 |
0 | Form 4 |
| 21 | KANAYA SUSAN M See Remarks |
2022-10-24 19:06:25 | 0 0 |
0 | Form 4 |
| 22 | Tyree James L Director |
2022-10-24 19:02:45 | 0 0 |
0 | Form 4 |
| 23 | FECZKO JOSEPH M Director |
2022-10-24 19:01:31 | 0 0 |
0 | Form 4 |
| 24 | Schall Thomas J. President and CEO |
2022-10-24 19:01:29 | 0 0 |
0 | Form 4 |
| 25 | Cappel Markus J. Chief Bus. Officer & Treasurer |
2022-10-24 18:58:24 | 0 0 |
0 | Form 4 |
| 26 | Butt Tausif EVP, Chief Operating Officer |
2022-10-24 18:57:30 | 0 0 |
0 | Form 4 |
| 27 | Wheadon David E. Director |
2022-10-24 18:58:04 | 0 0 |
0 | Form 4 |
| 28 | Duliege Anne-Marie EVP, Chief of Strategic Dev. |
2014-11-20 19:54:10 | 0 0 |
0 | Form 4 |
| 29 | GLAXOSMITHKLINE PLC Former 10% holder |
2018-10-18 17:03:29 | 0 0 |
0 | Form 4 |